cdmo.directory
← Compare landing

Northway Biotech vs Scinai Immunotherapeutics Ltd.

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryNorthway BiotechScinai Immunotherapeutics Ltd.
SummaryEnd-to-end CDMO specializing in protein-based biologics and gene therapies, with 20+ years of expertise and cGMP facilities in Lithuania and Massachusetts supporting development from preclinical to commercial stages.Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.
Services
  • Biologics Development & Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Process Development
  • Formulation Development
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • Biologics Development & Manufacturing
  • Recombinant Protein Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Biologics (Other)
  • Gene Therapy
  • Biologics (Monoclonal Antibodies)
Development capabilities
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Cell line development
  • Analytical method development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Microbial
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
Locations
  • Headquarters, Vilnius, Vilnius, Lithuania
  • US Facility, Waltham, Massachusetts, United States
  • Headquarters, Jerusalem, Israel
  • Yavne CDMO Facility, Yavne, Israel
CertificationsData not yet provided.
  • EMA · Identifier: European QP (EMA) audit passed
  • Israeli Ministry of Health · Identifier: Israeli MoH audit passed for Phase 3 clinical trial production

Find similar companies

Northway Biotech alternatives · Scinai Immunotherapeutics Ltd. alternatives

Markdown mirror: /compare/northway-biotech/scinai-immunotherapeutics.md